Principal Securities, Inc. Alkermes Plc. Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Principal Securities, Inc. holds 12 shares of ALKS stock, worth $330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 4
200.0%
Holding current value
$330
Previous $96,000
250.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
360Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$802 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$523 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$358 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$349 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$253 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.53B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...